OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers
Qing Zhang, Wenwen Chen, Xue Sun, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3498-3527
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Therapeutic application of natural products: NAD+ metabolism as potential target
Guo Chen, Qingxia Huang, Yisa Wang, et al.
Phytomedicine (2023) Vol. 114, pp. 154768-154768
Closed Access | Times Cited: 44

Recent advances in the therapeutic potential of emodin for human health
Javad Sharifi‐Rad, Jesús Herrera‐Bravo, Senem Kamiloğlu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113555-113555
Open Access | Times Cited: 51

Recent advances in the identification of biosynthetic genes and gene clusters of the polyketide-derived pathways for anthraquinone biosynthesis and biotechnological applications
Nitesh Kumar Mund, Eva Čellárová
Biotechnology Advances (2023) Vol. 63, pp. 108104-108104
Closed Access | Times Cited: 21

ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription
Dandan Wu, Zongchao Zuo, Xinning Sun, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116206-116206
Closed Access | Times Cited: 8

Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems
Li Song, Wei Zhang, Shiyun Tang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116039-116039
Open Access | Times Cited: 18

An azo bond primary cleavage and C–C bond secondary cleavage-based polymeric β-lapachone prodrug for selective anti-cancer therapy
Weidong Zhao, Mengfei Zheng, Hongyu Chu, et al.
Science China Materials (2025)
Closed Access

Polyporus umbellatus, A Precious Rare Fungus With Good Pharmaceutical and Food Value
Sizhu Ren, Liu Hua, Qing Sang, et al.
Engineering in Life Sciences (2025) Vol. 25, Iss. 1
Open Access

Biological activities of hydroxyanthracene derivatives (HADs) from Aloe species and their potential uses
Julio Enríquez Merino, Alexandra G. Durán, Nuria Chinchilla, et al.
Phytochemistry Reviews (2025)
Open Access

2-Chloromethyl Anthraquinone Inhibits Candida Albicans Biofilm Formation by Inhibiting the Ras1-cAMP-Efg1 Pathway
Haoying Zhang, Qi Zhang, Tianjian Zuo, et al.
Research in Microbiology (2025), pp. 104280-104280
Closed Access

Emodin activates autophagy to suppress oxidative stress and pyroptosis via mTOR-ULK1 signaling pathway and promotes multi-territory perforator flap survival
Panfeng Wu, Xiao Yu, Liming Qing, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 704, pp. 149688-149688
Closed Access | Times Cited: 4

Natural Products with Anti-tumorigenesis Potential Targeting Macrophage
Hao Liu, Manru Huang, Dandan Xin, et al.
Phytomedicine (2024) Vol. 131, pp. 155794-155794
Closed Access | Times Cited: 4

Emodin in-situ delivery with Pluronic F-127 hydrogel for myocardial infarction treatment: Enhancing efficacy and reducing hepatotoxicity
Yu Yao, Fuqiang Shao, Xiangfeng Peng, et al.
Life Sciences (2024) Vol. 354, pp. 122963-122963
Closed Access | Times Cited: 4

Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment
Chuansheng Yang, Xinpei Deng, Yunyun Tang, et al.
Cancer Letters (2024) Vol. 598, pp. 217116-217116
Closed Access | Times Cited: 3

Comprehensive investigation on the metabolism of emodin both in vivo and in vitro
Lin Zhou, Xiaohan Hu, Chunyue Han, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 223, pp. 115122-115122
Closed Access | Times Cited: 16

Emodin exhibits anti-acne potential by inhibiting cell growth, lipogenesis, and inflammation in human SZ95 sebocytes
Si Liu, Luo Xiaohua, Yufeng Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8

Emodin Sensitizes Cervical Cancer Cells to Vinblastine by Inducing Apoptosis and Mitotic Death
Wojciech Trybus, Ewa Trybus, Teodora Król
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8510-8510
Open Access | Times Cited: 10

Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects
Nicolette Casarcia, Patrick Rogers, Emma Guld, et al.
British Journal of Pharmacology (2023)
Closed Access | Times Cited: 5

Effect of Zn2+ on emodin molecules studied by time-resolved fluorescence spectroscopy and quantum chemical calculations
Anlan Huang, Anqi Hu, Lei Li, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2022) Vol. 289, pp. 122217-122217
Closed Access | Times Cited: 9

Natural Compounds for Bone Remodeling: Targeting osteoblasts and relevant signaling pathways
Zechao Qu, Song‐Chuan Zhao, Yong Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117490-117490
Open Access | Times Cited: 1

Advances in the treatment of pancreatic cancer with traditional Chinese medicine
Zhang Yan-hua, Hui Xu, Yue Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2

Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer
Yuan Gao, Youling Li, Yunhe Zhu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 5, pp. 510-518
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top